Floatz logo

FILGRASTIM

Decompensated Cirrhosis

Institute of Liver and Biliary Sciences, Indiaprotein_peptidePhase 3Active
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Decompensated Cirrhosis cohort.

Asset / SponsorPhaseRating
Avatrombopag
Tongji Hospital
Phase 4BB
L-Ornithine-L-Aspartate
Air Force Military Medical University, China
Phase 2/3B
Carboplatin
Genfit
Phase 2CCC
BIV201
BioVie Inc.
Phase 2CCC
Epirubicin
Genfit
Phase 2CCC

View all 12 →

Same molecule, other indications

FILGRASTIM is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
79 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →